<code id='B90C20017B'></code><style id='B90C20017B'></style>
    • <acronym id='B90C20017B'></acronym>
      <center id='B90C20017B'><center id='B90C20017B'><tfoot id='B90C20017B'></tfoot></center><abbr id='B90C20017B'><dir id='B90C20017B'><tfoot id='B90C20017B'></tfoot><noframes id='B90C20017B'>

    • <optgroup id='B90C20017B'><strike id='B90C20017B'><sup id='B90C20017B'></sup></strike><code id='B90C20017B'></code></optgroup>
        1. <b id='B90C20017B'><label id='B90C20017B'><select id='B90C20017B'><dt id='B90C20017B'><span id='B90C20017B'></span></dt></select></label></b><u id='B90C20017B'></u>
          <i id='B90C20017B'><strike id='B90C20017B'><tt id='B90C20017B'><pre id='B90C20017B'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:921
          Glaxo Smith Kline
          Akira Suemori/AP

          A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

          “The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

          advertisement

          Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Prescription digital therapeutics are key to pharma’s future
          Prescription digital therapeutics are key to pharma’s future

          AdobeFiveyearsfromnow,whenpatientswalkintoadoctor’sofficepresentingsymptomsofalmostanyconditionyouca

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Treatments for cramps don't cut it. Why aren't there better options?

          MollyFergusonforSTATOnedaylastfall,Kiran’speriodcrampsbecamesopainfultheywokeherupfromanap.The19-yea